Literature DB >> 1778750

Clinical and pathologic features of prostatic adenocarcinoma in sexually intact and castrated dogs: 31 cases (1970-1987).

F W Bell1, J S Klausner, D W Hayden, D A Feeney, S D Johnston.   

Abstract

The medical records of 31 dogs diagnosed with prostatic carcinoma at the teaching hospital between January 1970 and October 1987 were reviewed to determine whether gender status had an effect on the clinical features or biologic behavior of the disease. The only significant difference between sexually intact and castrated dogs was increased prevalence of pulmonary metastasis in castrated dogs.

Entities:  

Mesh:

Year:  1991        PMID: 1778750

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  25 in total

1.  Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cells.

Authors:  Lisa Y Wu; Jacqueline M Johnson; Jessica K Simmons; Desiree E Mendes; Jonathan J Geruntho; Tiancheng Liu; Wessel P Dirksen; Thomas J Rosol; William C Davis; Clifford E Berkman
Journal:  Prostate       Date:  2014-01-21       Impact factor: 4.104

2.  Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis.

Authors:  Said M Elshafae; Wessel P Dirksen; Aylin Alasonyalilar-Demirer; Justin Breitbach; Shiyu Yuan; Noriko Kantake; Wachiraphan Supsavhad; Bardes B Hassan; Zayed Attia; Lucas B Alstadt; Thomas J Rosol
Journal:  Prostate       Date:  2020-04-29       Impact factor: 4.104

3.  Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.

Authors:  Radmehr Shafiee; Alireza Shariat; Soheil Khalili; Hamed Zamankhan Malayeri; Aram Mokarizadeh; Ali Anissian; Mohammad Reza Hafezi Ahmadi; Ehsan Hosseini; Mostafa Naderafif; Siamak Mohsenzadeh; Mohammad Hosein Rasoulian; Reza Rezapour; Maryam Pourzaer
Journal:  Tumour Biol       Date:  2014-11-25

Review 4.  A Review on Canine and Feline Prostate Pathology.

Authors:  Chiara Palmieri; Carlos Eduardo Fonseca-Alves; Renee Laufer-Amorim
Journal:  Front Vet Sci       Date:  2022-05-26

5.  Melphalan, alone or conjugated to an FSH-β peptide, kills murine testicular cells in vitro and transiently suppresses murine spermatogenesis in vivo.

Authors:  John K Amory; SungWoo Hong; Xiaozhong Yu; Charles H Muller; Elaine Faustman; Alex Goldstein
Journal:  Theriogenology       Date:  2014-03-27       Impact factor: 2.740

6.  Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer.

Authors:  Katharina A Sterenczak; Martin Meier; Silke Glage; Matthias Meyer; Saskia Willenbrock; Patrick Wefstaedt; Martina Dorsch; Jörn Bullerdiek; Hugo Murua Escobar; Hans Hedrich; Ingo Nolte
Journal:  BMC Cancer       Date:  2012-07-11       Impact factor: 4.430

7.  Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258.

Authors:  Melani A M Fork; Hugo Murua Escobar; Jan T Soller; Katharina A Sterenczak; Saskia Willenbrock; Susanne Winkler; Martina Dorsch; Nicola Reimann-Berg; Hans J Hedrich; Jörn Bullerdiek; Ingo Nolte
Journal:  BMC Cancer       Date:  2008-08-15       Impact factor: 4.430

8.  Detection of BRAF Mutation in Urine DNA as a Molecular Diagnostic for Canine Urothelial and Prostatic Carcinoma.

Authors:  Hiroyuki Mochizuki; Susan G Shapiro; Matthew Breen
Journal:  PLoS One       Date:  2015-12-09       Impact factor: 3.240

9.  Generation and characterisation of a canine EGFP-HMGA2 prostate cancer in vitro model.

Authors:  Saskia Willenbrock; Siegfried Wagner; Nicola Reimann-Berg; Mohammed Moulay; Marion Hewicker-Trautwein; Ingo Nolte; Hugo Murua Escobar
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

10.  Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells.

Authors:  Tatsuya Usui; Masashi Sakurai; Shimpei Nishikawa; Koji Umata; Yuki Nemoto; Tomoya Haraguchi; Kazuhito Itamoto; Takuya Mizuno; Shunsuke Noguchi; Takashi Mori; Satomi Iwai; Takayuki Nakagawa; Hideyuki Yamawaki; Takashi Ohama; Koichi Sato
Journal:  Cancer Sci       Date:  2017-11-06       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.